{
  "id": 777208,
  "title": "Eurofins CDMO Alphora Expands Kilolab and High Potency Development and Manufacturing Capabilities",
  "url": "https://urgent.news/2026/08/13/eurofins-cdmo-alphora-expands-kilolab-and-high-potency-development",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-13T14:04:39.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/pmn/business-wire-news-releases-pmn/eurofins-cdmo-alphora-expands-kilolab-and-high-potency-development-and-manufacturing-capabilities"
  },
  "original_language": "en",
  "account": null,
  "summary": "MISSISSAUGA, Ontario — Eurofins CDMO Alphora has expanded its kilolab and high-potency active pharmaceutical ingredient (HPAPI) development and manufacturing capabilities in Mississauga. The expanded laboratories are designed to support the growing demand for enhanced flexibility as part of process development, scale-up, and manufacturing activities for non-high potent and high potent programs.…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}